Results 71 to 80 of about 26,795 (236)

Myoclonus in Ataxia-Telangiectasia

, 2015
Background: Various movement disorders can be found in ataxia-telangiectasia (AT), including ataxia, dystonia, chorea, and myoclonus, but myoclonus has rarely been described as the predominant feature in AT.
Amy C. Yang, Steven J. Frucht, Frucht, Steven J., Termsarasab, Pichet, Yang, Amy C., Pichet Termsarasab   +5 more
core   +1 more source

Epilepsy syndromes classification

Epilepsia Open, EarlyView.
Abstract Epilepsy syndromes are distinct electroclinical entities which have been recently defined by the International League Against Epilepsy Nosology and Definitions Task Force. Each syndrome is associated with “a characteristic cluster of clinical and EEG features, often supported by specific etiologic findings”.
Elaine C. Wirrell, Nicola Specchio, Rima Nabbout, Phillip L. Pearl, Kate Riney   +4 more
wiley   +1 more source

Large fasciculation can clinically manifest as spinal myoclonus; electromyographic and dynamic echomyographic studies of four cases with motor neuron disease

Clinical Neurophysiology Practice, 2018
Objective: Patients with motor neuron disease rarely present with fasciculation which is large enough to be clinically recognized as myoclonus. This study is aimed at elucidating the features of large fasciculation manifesting as myoclonus by using ...
Manabu Inoue, Masayoshi Yamamoto, Koji Tsuzaki, Toshiaki Hamano, Hiroaki Etoh, Hiroshi Shibasaki   +5 more
doaj   +1 more source

Genetic epilepsies with myoclonic seizures: Mechanisms and syndromes

Epilepsia Open, EarlyView.
Abstract Genetic epilepsy with myoclonic seizures encompasses a heterogeneous spectrum of conditions, ranging from benign and self‐limiting forms to severe, progressive disorders. While their causes are diverse, a significant proportion stems from genetic abnormalities.
Antonietta Coppola, Marica Rubino, Antonella Riva, Pasquale Striano   +3 more
wiley   +1 more source

Post-hypoxic myoclonus: Differentiating benign and malignant etiologies in diagnosis and prognosis

Clinical Neurophysiology Practice, 2017
Neurological function following cardiac arrest often determines prognosis. Objective tests, including formal neurological examination and neurophysiological testing, are performed to provide medical providers and decision-makers information to help guide
Brin Freund, Peter W. Kaplan
doaj   +1 more source

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

Epilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang, Emilio Perucca, Samuel F. Berkovic, Piero Perucca   +3 more
wiley   +1 more source

Absence seizures: Update on signaling mechanisms and networks

Epilepsia Open, EarlyView.
Abstract Absence seizures (AS) are a hallmark of genetic generalized epilepsies (GGE), characterized by brief episodes of impaired consciousness accompanied by electroencephalographic spike‐and‐wave discharges (SWDs). Traditionally attributed to cortico‐thalamo‐cortical (CTC) dysrhythmia, emerging evidence suggests a more intricate pathophysiological ...
Ozlem Akman, Filiz Onat
wiley   +1 more source

Effect of butorphanol on etomidate-induced myoclonus: a systematic review and meta-analysis

Drug Design, Development and Therapy, 2019
Jun Hua,1 Shuai Miao,2 Mengzhu Shi,2 Qing Tu,3 Xiuli Wang,2 Su Liu,2 Guanglei Wang,2 Jianhui Gan31Department of Anesthesiology, The 101 Hospital of Chinese People’s Libration Army, Wuxi, Jiangsu, People’s Republic of China; 2Department of ...
Hua J, Miao S, Shi M, Tu Q, Wang X, Liu S, Wang G, Gan J   +7 more
doaj  

Negative myoclonus as a manifestation of cefepime neurotoxicity

Clinical Case Reports
Key Clinical Message Negative myoclonus may present in the early stages of cefepime neurotoxicity. Cefepime neurotoxicity typically presents as reduced consciousness, myoclonus, and seizures; however, negative myoclonus is uncommon.
Daichi Umemoto, Hirokazu Kuroda, Hiroaki Nishioka   +2 more
doaj   +1 more source

Lower significant rate of etomidate-induced myoclonus for procedural sedation in emergency department of a tertiary care hospital

National Journal of Physiology, Pharmacy and Pharmacology, 2018
Background: Etomidate drug is commonly used for procedural sedation in the emergency department (ED). The incidence rate of etomidate-induced myoclonus is 33%.
Ashly Alexander Fernandez, Neethu C M
doaj   +1 more source